Clobetasol Propionate Cream Recalled Due to cGMP Deviations
Teligent Pharma is recalling all unexpired batches of Clobetasol Propionate Cream USP 0.05% nationwide because the manufacturer is discontinuing its stability study program and cannot ensure compliance with current Good Manufacturing Practice standards.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall based on the agency classification. The recall is precautionary in nature—driven by manufacturing process deviations and discontinuation of stability testing—with no reported illnesses or injuries. The hazard is regulatory non-compliance rather than an acute safety threat.
Plain-English summary
Teligent Pharma, Inc. is recalling Clobetasol Propionate Cream USP, 0.05%, distributed nationwide in the USA and Puerto Rico. The recall affects all products within their expiration dates across four package sizes: 15-gram tubes (NDC 52565-051-15), 30-gram tubes (NDC 52565-051-30), 45-gram tubes (NDC 52565-051-45), and 60-gram tubes (NDC 52565-051-60). A total of 207,933 tubes are being recalled.
The reason for the recall is cGMP (current Good Manufacturing Practice) deviations. Specifically, the firm is discontinuing its stability study program, which is required to demonstrate that the product maintains its safety and effectiveness throughout its shelf life.
Consumers who have this product should stop using it and contact their pharmacy or healthcare provider with questions. Healthcare providers and pharmacies should identify and return the affected product to the manufacturer.
The recalled product
- Product
- Clobetasol Propionate Cream USP, 0.05%, packaged in a) 15 grams tube, NDC 52565-051-15; b) 30 grams tube, NDC 52565-051-30; c) 45 grams tube, NDC 52565-051-45; d) 60 grams tube, NDC 52565-051-60; Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical / Corticosteroid
- Affected units
- 207,933
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- Batch: a) 15803
- Exp. 7/31/2022
- 16237
- Exp. 11/30/2022
- b) 15803
- 16388
- Exp. 2/28/2023
- c) 15605
- d) 15605
- 15860
- Exp. 8/31/2022
- 16001
- Exp. 9/30/2022
- 16344
- Exp. 1/31/2023
- 16294
- 16474
- 16543
- Exp. 2/28/2023.
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Vancomycin Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09